Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock

[1]  B. Levy,et al.  Human Sepsis Eicosanoid and Proresolving Lipid Mediator Temporal Profiles: Correlations With Survival and Clinical Outcomes , 2017, Critical care medicine.

[2]  M. Bauer,et al.  Metabolite Profiles in Sepsis: Developing Prognostic Tools Based on the Type of Infection* , 2016, Critical care medicine.

[3]  H. P. Leite,et al.  Metabolic resuscitation in sepsis: a necessary step beyond the hemodynamic? , 2016, Journal of thoracic disease.

[4]  David J. Midmore,et al.  Biochar, Bentonite and Zeolite Supplemented Feeding of Layer Chickens Alters Intestinal Microbiota and Reduces Campylobacter Load , 2016, PloS one.

[5]  Ida Zarina Zaini,et al.  CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department , 2016, PloS one.

[6]  R. Bellomo,et al.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). , 2016, JAMA.

[7]  M. Ferrario,et al.  Mortality prediction in patients with severe septic shock: a pilot study using a target metabolomics approach , 2016, Scientific Reports.

[8]  D. Angus,et al.  Assessment of Global Incidence and Mortality of Hospital-treated Sepsis. Current Estimates and Limitations. , 2016, American journal of respiratory and critical care medicine.

[9]  G. Schmid-Schönbein,et al.  ShockOmics: multiscale approach to the identification of molecular biomarkers in acute heart failure induced by shock , 2016, Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine.

[10]  Oliver Fiehn,et al.  Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics. , 2016, Analytical chemistry.

[11]  Won‐Kyo Jung,et al.  Gallic Acid-g-Chitosan Modulates Inflammatory Responses in LPS-Stimulated RAW264.7 Cells Via NF-κB, AP-1, and MAPK Pathways , 2016, Inflammation.

[12]  A. Sauaia,et al.  Pathologic metabolism: An exploratory study of the plasma metabolome of critical injury , 2015, The journal of trauma and acute care surgery.

[13]  C. Lindsell,et al.  Developing a clinically feasible personalized medicine approach to pediatric septic shock. , 2015, American journal of respiratory and critical care medicine.

[14]  I. Maričić,et al.  Recognition of Lysophosphatidylcholine by Type II NKT Cells and Protection from an Inflammatory Liver Disease , 2014, The Journal of Immunology.

[15]  Sang-Bum Hong,et al.  Impact of serial measurements of lysophosphatidylcholine on 28-day mortality prediction in patients admitted to the intensive care unit with severe sepsis or septic shock. , 2014, Journal of critical care.

[16]  A. Stevenson,et al.  An Evaluation of Dose Equivalence between Synchrotron Microbeam Radiation Therapy and Conventional Broadbeam Radiation Using Clonogenic and Cell Impedance Assays , 2014, PloS one.

[17]  H. Vogel,et al.  Metabolic Profiling of Serum Samples by 1H Nuclear Magnetic Resonance Spectroscopy as a Potential Diagnostic Approach for Septic Shock* , 2014, Critical care medicine.

[18]  Vance G. Fowler,et al.  Metabolomic Derangements Are Associated with Mortality in Critically Ill Adult Patients , 2014, PloS one.

[19]  S. Caspar-Bauguil,et al.  Alteration of plasma phospholipid fatty acid profile in patients with septic shock. , 2013, Biochimie.

[20]  Stephanie J. Reisinger,et al.  An Integrated Clinico-Metabolomic Model Improves Prediction of Death in Sepsis , 2013, Science Translational Medicine.

[21]  A. Zell,et al.  Circulating Lysophosphatidylcholines Are Markers of a Metabolically Benign Nonalcoholic Fatty Liver , 2013, Diabetes Care.

[22]  T. Bertsch,et al.  Reduced plasmalogen concentration as a surrogate marker of oxidative stress in elderly septic patients. , 2013, Archives of gerontology and geriatrics.

[23]  U. Schuler,et al.  Plasma Levels of Phospholipase A2-IIA in Patients with Different Types of Malignancies: Prognosis and Association with Inflammatory and Coagulation Biomarkers , 2013, Pathology & Oncology Research.

[24]  R. Fanelli,et al.  A combination of untargeted and targeted metabolomics approaches unveils changes in the kynurenine pathway following cardiopulmonary resuscitation , 2013, Metabolomics.

[25]  C. Sprung,et al.  Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012 , 2013, Intensive Care Medicine.

[26]  N. Tanaka,et al.  Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis , 2012, Hepatology.

[27]  F. Brunkhorst,et al.  Targeted metabolomics for discrimination of systemic inflammatory disorders in critically ill patients[S] , 2012, Journal of Lipid Research.

[28]  V. Gebski,et al.  Tryptophan metabolism to kynurenine is a potential novel contributor to hypotension in human sepsis* , 2011, Critical care medicine.

[29]  Nicola Zamboni,et al.  High-throughput, accurate mass metabolome profiling of cellular extracts by flow injection-time-of-flight mass spectrometry. , 2011, Analytical chemistry.

[30]  T. J. Cunningham,et al.  Product inhibition of secreted phospholipase A2 may explain lysophosphatidylcholines' unexpected therapeutic properties , 2008, Journal of Inflammation.

[31]  Mervyn Singer,et al.  Cellular energetic metabolism in sepsis: the need for a systems approach. , 2008, Biochimica et biophysica acta.

[32]  S. V. van Deventer,et al.  Alterations in lipoprotein homeostasis during human experimental endotoxemia and clinical sepsis. , 2007, Biochimica et biophysica acta.

[33]  James A Russell,et al.  Early changes in organ function predict eventual survival in severe sepsis* , 2005, Critical care medicine.

[34]  A. Bunck,et al.  Role of increased sphingomyelinase activity in apoptosis and organ failure of patients with severe sepsis , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[35]  H. Zou,et al.  Regularization and variable selection via the elastic net , 2005 .

[36]  Fuhui Long,et al.  Feature selection based on mutual information criteria of max-dependency, max-relevance, and min-redundancy , 2003, IEEE Transactions on Pattern Analysis and Machine Intelligence.

[37]  Ronald J A Wanders,et al.  Functions and biosynthesis of plasmalogens in health and disease. , 2004, Biochimica et biophysica acta.

[38]  G. Schmitz,et al.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.

[39]  R. Zoeller,et al.  Increasing plasmalogen levels protects human endothelial cells during hypoxia. , 2002, American journal of physiology. Heart and circulatory physiology.

[40]  E. Goetzl,et al.  Lysophospholipids and their G protein-coupled receptors in inflammation and immunity. , 2002, Biochimica et biophysica acta.

[41]  J. Vincent,et al.  Serial evaluation of the SOFA score to predict outcome in critically ill patients. , 2001, JAMA.

[42]  G. Clermont,et al.  Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care , 2001, Critical care medicine.

[43]  P. Calder,et al.  The inhibition of T-lymphocyte proliferation by fatty acids is via an eicosanoid-independent mechanism. , 1992, Immunology.